• Login
Redica Systems
  • For Pharma

    Our data generates critical pharma insights with our actionable data intelligence helping your team go from reactive to proactive.

    For MedTech

    Elevate your MedTech quality and regulatory strategies with our comprehensive intelligence solutions and unparalleled dataset.

  • Catalyst
  • About Us
    • People
    • Careers
    • Press
  • Resources

    View all Resources

    • Assessments
    • Reports
    • Webinars
    • Glossary
  • Blog
Request a Demo
Redica Systems
    • Redica Systems MedTech Intelligence
    • Redica Systems Pharma Intelligence
  • Catalyst
    • About Redica Systems
    • People
    • Careers
    • Press
  • Resources
  • Blog
Request a Demo
  • Login

Resources

FDA cGMP Quality News Briefing: August-September

We’ve compiled August and September’s mostrelevant, important news foranyone concerned with Pharmaceutical Industry GMP and FDA inspections. Our top 12 picks are listed chronologically by publication date.Happy reading! July 25: After scandal, China begins vaccine inspections nationwide. — Discovery of a blackmarket vaccine ring earlier this year was the impetus for China’s nationwide campaign to inspect vaccine […]

17 New Featured FDA 483s | September 27, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 1/22/2016 Amgen Manufacturing Limited Juncos PR United States 2/23/2015 Carlos Pantojas San Juan PR United States 9/25/2015 Charles River Laboratories Preclinical Services Reno NV United States 11/2/2015 Comprehensive Telemedicine […]

3 Key Learnings from the PDA/FDA Joint Conference

OVERALL:This is the 25th anniversary of the PDA/FDA conference and many of the presentations provided evidence of the significant progress made in research and medicine during this time.It was fascinating to stand back for a few moments to see just how far we’ve come.The overall conclusion I take from the two days of the conference […]

22 New Featured FDA 483s | September 20, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 3/17/2014 Antonio Capone Royal Oak MI United States 10/14/2015 Applied BioPhotonics Ltd. Chupei City, Hsinchu District Taiwan (Province of China) 12/10/2015 Biogen US Corporation Research Triangle Park NC United […]

22 New Featured FDA 483s | September 13, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 12/2/2015 Adapta Medical, Inc. Colorado Springs CO United States 9/18/2015 Apnea Sciences Corporation Aliso Viejo CA United States 11/9/2015 Ascent Pharmaceuticals, Inc. Central Islip NY United States 12/14/2015 Austin […]

22 New Featured FDA 483s | September 6, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 12/2/2015 Adapta Medical, Inc. Colorado Springs CO United States 7/30/2015 Advanced OrthoPro, Inc. Indianapolis IN United States 5/21/2014 AMAG Pharmaceuticals, Inc. Waltham MA United States 11/10/2010 Apinya B. Vutikullird, […]

22 New Featured FDA 483s | August 30, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 5/23/2014 21st Century Oncology, Inc. Naples FL United States 1/22/2016 Boston Scientific Neuromodulation Corporation Valencia CA United States 10/25/2013 Bushu Pharmaceuticals Ltd. Kawagoe-shi Japan 9/17/2015 CMR Naviscan Corporation Carlsbad […]

The Story of 3 Consent Decrees

A consent decree agreement is an agreement filed in the US courts formalizing a voluntary agreement between two parties. Here we will address consent decree agreements between FDA and several pharmaceutical companies based on repeated failures to adequately address CGMP deficiencies. It is not an action taken on the basis of a single form 483, […]

Haven’t visited us for a while? Get up to speed in 4 minutes

If you haven’t been to FDAzilla.com in a while, then you’ve come to the right place. If any part of your job involves preparing your company for FDA GMP inspections, let me take you on a quick tour of some tools and resources that you might find useful!  Take 4 minutes and check out these 4 […]

Last 30 483s Customers Have Purchased – July 2016

We see a lot of people, all throughout the world, purchasing 483s from our FDA 483s store. For example, this month, customers from Japan, Italy, China, United Kingdom, and the United States purchased 483s.  As a reminder, here are 5 features to look for in a 483. Here are the latest 30 483s purchased from us: […]
« Older Entries
Newer Entries »
Company
  • About Redica Systems
  • People
  • Careers
  • Press
  • Contact Us
Catalyst
  • Redica Catalyst
  • Redica ID
  • Enrichment
  • Knowledge Graph
  • Redica Ontologies
Use Cases
  • For Pharma
  • For MedTech
  • Inspection Preparation
  • Vendor Quality
  • Regulatory Surveillance
Resources
  • Assessments
  • Reports
  • Webinars
  • Document Store
  • Blog
  • Glossary

© 2025 Redica. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Status